1. Home
  2. Search

Search

Search results

35 results found

Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats.

Publication: Journal Article
M, Das, Mayilsamy K, Tang X, Han JY, Foran E, Willing AE, Mohapatra SS, and Mohapatra S. 2019. “Pioglitazone Treatment Prior to Transplantation Improves the Efficacy of Human Mesenchymal Stem Cells After Traumatic Brain Injury in Rats.”. Sci Rep. 2019 Sep 20;9(1):13646. Doi: 10.1038/S41598-019-49428-Y. PMID: 31541141; PMCID: PMC6754424.

Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury.

Publication: Journal Article
K, Mayilsamy, Markoutsa E, Das M, Chopade P, Puro D, Kumar A, Gulick D, Willing AE, Mohapatra SS, and Mohapatra S. 2020. “Treatment With ShCCL20-CCR6 Nanodendriplexes and Human Mesenchymal Stem Cell Therapy Improves Pathology in Mice With Repeated Traumatic Brain Injury.”. Nanomedicine. 2020 Oct;29:102247. Doi: 10.1016/J.Nano.2020.102247. 32 (7): 1789-1804.

Dr. Subhra Mohapatra Invents "Tumor-on-a-disc" Technology

News: August 29, 2024
As reported by the United States Patent and Trademark Office: Subhra Mohapatra, a researcher at the University of South Florida and fellow of the National Academy of Inventors, invented “tumor-on-a-disc" technology that enables scientists to grow tumors in the lab to help treat and understand cancer...

A mouse model of repeated traumatic brain injury-induced hearing impairment: Early cochlear neurodegeneration in the absence of hair cell loss.

Publication: Journal Article
C, Penn, Mayilsamy K, Zhu XX, Bauer MA, Mohapatra SS, Frisina RD, and Mohapatra S. 2023. “A Mouse Model of Repeated Traumatic Brain Injury-Induced Hearing Impairment: Early Cochlear Neurodegeneration in the Absence of Hair Cell Loss.”. Hear Res. 2023 Sep 1;436:108832. Doi: 10.1016/J.Heares.2023.108832. Epub 2023 Jun 19. PMID: 37364367.